| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $150.9M | -43.1% |
| SG&A Expense | $45.1M | -21.3% |
| Operating Income | -$196.1M | +39.2% |
| Net Income | -$185.7M | +42.0% |
| EPS (Basic) | -$2.14 | +57.7% |
| EPS (Diluted) | -$2.14 | +57.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $66.4M | -23.8% |
| Short-term Investments | $104.4M | -45.8% |
| Current Assets | $179.9M | -41.8% |
| Total Assets | $243.6M | -37.0% |
| Current Liabilities | $36.6M | +21.8% |
| Total Liabilities | $74.8M | -1.6% |
| Stockholders' Equity | $168.8M | -45.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$116.5M | +58.4% |
| Capital Expenditures | $592K | -92.9% |
| Investing Cash Flow | $93.2M | +30.0% |
| Financing Cash Flow | $2.5M | -98.2% |
| Free Cash Flow | -$117.1M | +59.4% |